On April 26, 2026, the EU will mandatorily implement the new radiofrequency exposure standard EN 62209-3:2026, requiring wireless sensor products intended for close-proximity use near the human body (such as wearable health sensors and industrial handheld RFID readers) to pass Specific Absorption Rate (SAR) testing based on realistic human tissue liquid models. This requirement will directly affect Chinese manufacturers of radiofrequency sensors exporting to Europe, testing and certification bodies, and trade service providers, as it is directly tied to CE marking compliance and a tightening shipment window.

Event Overview

The EU will officially mandate the implementation of standard EN 62209-3:2026 on April 26, 2026. The standard stipulates that all wireless radiofrequency sensor devices intended to operate within 10 cm of the human body must undergo SAR value assessment based on updated simulated human tissue liquid models. Starting from July 1, 2026, products that have not completed testing and obtained the corresponding certification under this standard may not bear the CE mark, nor may they be placed on or circulated in the EU market.

Which market segments will be affected

Direct trading enterprises: mainly refers to Chinese exporters that export radiofrequency sensor products to the EU under their own brands or via OEM arrangements. As the CE mark is a mandatory market entry threshold, existing inventory that has not been certified under the new standard will be unable to clear customs or be listed for sale after July 1, 2026; the impact will include delayed order deliveries, increased return risks, and more customer requests for renewed factory audits/verification.

Processing and manufacturing enterprises: including wearable device contract factories, RFID module assembly plants, and similar operations. Their production processes must adapt to the new testing requirements, such as adjusting antenna layouts, shielding structures, or housing materials to control SAR values; the impact will include longer design verification cycles, higher small-batch trial production costs, and the need for some models to be resubmitted for inspection.

Supply chain service enterprises: specifically referring to third-party service institutions that provide EMC/radio safety testing, certification agency services, and technical compliance consulting. The new standard introduces human tissue liquid modeling tests, imposing higher requirements on laboratory equipment configuration (such as specific dielectric constant liquid tanks and high-precision electric field probes) and tester qualifications; the impact will include tight testing schedules, possible increases in per-test costs, and the temporary inability of some small and medium-sized institutions to offer full-scope capabilities.

What key points should relevant companies or practitioners pay attention to, and how should they respond at present

Pay attention to the clearly defined compliance deadlines and transitional arrangements

Confirm whether your products fall within the scope of EN 62209-3:2026 (that is, radiofrequency sensors operating at 30 MHz–6 GHz and within ≤10 cm of the human body), and strictly align with the July 1, 2026 CE marking prohibition deadline. Note that this date is the mandatory effective date, and no officially announced grace period or continuation policy for the old standard has been published.

Sort out key export categories and corresponding model lists

Give priority to identifying categories that are frequently exported and used close to the human body, such as smart wristbands/chest-strap heart rate sensors, UHF RFID handheld terminals for industrial inspection, and medical-grade Bluetooth temperature patches; establish a ledger for each model covering “test status—report number—certification body—validity period” to avoid entire shipments being held at port due to omitted models.

Launch testing resource coordination and technical contingency plans in advance

Given that human tissue liquid model testing cycles are usually longer than traditional EMC testing (requiring customized liquid formulations, temperature calibration, and multi-angle scanning), it is recommended to contact laboratories qualified for EN 62209-3:2026 before Q2 2026 to reserve testing slots; at the same time, assess whether PCB antenna designs need adjustment or absorbing materials need to be added, and reserve time for at least 2 rounds of rectification + retesting.

Distinguish between the standard text requirements and the actual enforcement scope

At present, public information only clearly specifies the test methods and the timing of the prohibition, while the specific enforcement details by market surveillance authorities (MSA) in individual EU member states for scenarios such as existing inventory and already-signed contract orders have not yet been disclosed; enterprises should continuously monitor public documents from the European Committee for Standardization (CEN/CENELEC) and the European Commission, and should not treat unofficial industry interpretations as equivalent to regulatory directives.

Editorial Viewpoint / Industry Observation

Obviously, this standard update is less a technical refinement and more a regulatory hardening of human exposure accountability for proximity RF devices. It signals a shift from generic device-level EMC compliance toward biologically contextualized safety validation — particularly relevant as sensor miniaturization and body-worn deployment accelerate.

Analysis shows the timing (2026 Q2 implementation) suggests deliberate alignment with broader EU digital product sustainability frameworks, though no direct linkage to Ecodesign or CE marking reform has been confirmed. The absence of transitional provisions indicates enforcement readiness across major notified bodies.

From an industry perspective, this is not merely a certification checkbox: it reflects tightening convergence between radio equipment regulation and health-oriented product policy. Continuous monitoring of test methodology updates (e.g., tissue-equivalent liquid composition revisions) will be more consequential than one-time compliance.

Conclusion: The implementation of EN 62209-3:2026 marks the EU's safety regulation of radiofrequency sensor products entering a biophysical modeling stage, with its core significance lying in extending Electromagnetic Compatibility (EMC) testing into the dimension of human-body interaction. At present, it is more appropriately understood as an already implemented mandatory market access condition rather than a policy signal pending observation; relevant enterprises should advance testing and certification according to a definite timeline and should not expect postponements or exemptions.

Source note: primarily based on announcements published in the Official Journal of the European Union (OJEU) and the EN 62209-3:2026 standard text issued by CENELEC. As for details such as specific enforcement interpretations by national market surveillance authorities, updates to lists of qualified testing institutions, and other particulars, continued observation of subsequent notices from the European Commission and the National Accreditation Bodies (NAB) of member states is still required.